Dietary Intake of Natural Sources of Docosahexaenoic Acid and Folate in Pregnant Women of Three European Cohorts by Franke, Corinna et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Ann Nutr Metab 2008;53:167–174 
 DOI: 10.1159/000172978 
 Dietary Intake of Natural Sources of
Docosahexaenoic Acid and Folate in Pregnant 
Women of Three European Cohorts 
 C. Franke a    S. Verwied-Jorky a    C. Campoy c    M. Trak-Fellermeier a    T. Decsi b    
V. Dolz c    B. Koletzko a 
 a  Division of Metabolism and Nutrition, Dr. von Hauner Children’s Hospital,  Munich , Germany;  b Department of 
Pediatrics, University of Pécs,  Pécs , Hungary;  c  Department of Pediatrics, University of Granada,  Granada , Spain 
of the participants reached the recommended folate intake 
during pregnancy, whereas nearly 90% reached the DHA 
recommended intake of 200 mg per day. 
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 Introduction 
 Nutrient requirements increase markedly during 
pregnancy to support fetal growth and expansion of ma-
ternal tissues. The quality of nutrient supply during preg-
nancy is associated with maternal health, pregnancy out-
come, rate of complications as well as fetal development 
and growth  [1, 2] . Poor maternal nutrition is one of the 
key factors leading to compromised fetal growth and ad-
verse effects on child health  [3] . Pregnant women often 
do not meet their increased nutrient needs, particularly 
of folic acid  [4–6] . Folate deficiency is one of the most 
common vitamin deficiencies worldwide  [7] . This vita-
min is essential for DNA synthesis, amino acid metabo-
lism and cell division  [8, 9] . Poor folate status during ear-
ly pregnancy is associated with increased rates of neural 
tube defects  [10–12] . Moreover, poor folate supply can 
lead to increased plasma homocysteine, an established 
risk factor of placental abruption, preterm delivery and 
increased rates of low birth weight  [13, 14] . Considering 
these facts, an optimal supply with folate during the 
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 Abstract 
 Background: Folic acid plays a fundamental role in cell divi-
sion and differentiation. Docosahexaenoic acid (DHA) has 
been associated with infantile neurological and cognitive 
development. Thus, optimal intrauterine development and 
growth requires adequate supply of these nutrients during 
pregnancy.  Methods: Healthy pregnant women, aged 18–41 
years, were recruited in Granada (Spain; n = 62), Munich (Ger-
many; n = 97) and Pécs (Hungary; n = 152). We estimated di-
etary DHA and folate intake in weeks 20 (w20) and 30 of ges-
tation (w30) using a food frequency questionnaire with 
specific focus on the dietary sources of folate and DHA.  Re-
sults: Both w20 and w30 Spanish participants had signifi-
cantly higher daily DHA intakes (155  8 13 and 161  8 9 
mg/1,000 kcal) than the German (119  8 9 and 124  8 12 
mg/1,000 kcal; p = 0.002) and Hungarian participants (122  8 
8 and 125  8 10 mg/1,000 kcal; p = 0.005). Hungarian women 
had higher folate intakes in w20 and w30 (149  8 5 and 147 
 8 6   g/1,000 kcal) than Spanish (112  8 2 and 110  8 
2   g/1,000 kcal; p  ! 0.001) and German participants (126  8 
4 and 120  8 6   g/1,000 kcal; p  ! 0.001), respectively.  Conclu-
sion: Dietary DHA and folate intake of pregnant women dif-
fers significantly across the three European cohorts. Only 7% 
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whole pregnancy – not only at the beginning – might im-
prove pregnancy outcome  [15] .
 Food provides two forms of folate, pteroylmono-
glutamate and pteroylpolyglutamate. These two forms 
differ in their bioavailability, because a hydrolysis of the 
polyglutamate side chain is necessary before absorption. 
The estimated average bioavailability of folate from om-
nivorous diets is about 50%  [15] , whereas synthetic folic 
acid from supplements is almost completely available for 
the metabolism  [16] . Folate is sensitive to heat and light, 
and is easily oxidized during food preparation. Thus, it 
is hard to achieve a well-balanced folate supply from 
food  [17] , and pregnant women are recommended to 
consume synthetic folic acid from fortified foods, sup-
plements or both, in addition to consuming folate from 
a varied diet. However, there exists no single recom-
mended value for women in childbearing age or preg-
nant women throughout Europe. On average, a supple-
mentation of 400   g/day of folic acid is recommended 
(e.g. Germany: 600   g/day, Hungary and Spain: 400   g/
day)  [18, 19] .
 A further nutrient with particular relevance for peri-
natal development is docosahexaenoic acid (DHA), an n-
3 long-chain polyunsaturated fatty acid (FA) mainly 
found in fatty sea fish  [20] . DHA is an indispensable com-
ponent of all cell membranes in the brain and other tis-
sues, with major relevance for fetal neurological develop-
ment  [21–24] . In the last 3 months of gestation, the fetus 
accumulates up to 50 mg DHA per day in the brain and 
adipose tissue  [25] . After birth, breast-fed infants are pro-
vided with DHA through breast milk. Several controlled 
studies found that DHA availability during pregnancy is 
associated with improved cognitive and visual develop-
ment as well as reduced risk of early preterm birth  [26–
28] . Therefore, an average dietary DHA intake of at least 
200 mg/day has been recommended for pregnant and 
breast-feeding women  [29] .
 Given the relevance of DHA and folate supply during 
pregnancy, we assessed the dietary intake of these nutri-
ents in women participating in the Nutraceuticals for a 
Healthier Life (NUHEAL) Study in Germany, Hungary 
and Spain, to obtain data on current dietary intakes dur-
ing pregnancy in these European cohorts.
 Subjects and Methods 
 Subjects and Recruitment 
 The study population was comprised of the participants of the 
NUHEAL Study, a prospective cohort study, which compared the 
effects of dietary supplementation with DHA and/or methyltet-
rahydrofolate from week 21 of gestation until child birth in moth-
ers from three different European countries  [30, 31] .
 From November 2001 to March 2003, apparently healthy preg-
nant women (aged 18–41 years) attending antenatal care clinics 
were recruited between week 12 and 20 of gestation. Recruitment 
took place at three study sites: the University Hospital of Granada 
in Spain, the Ludwig Maximilians University in Munich, Ger-
many, and the University of Pécs, Hungary. Further inclusion cri-
teria were: body weight at study entry between 50 and 92 kg, un-
complicated singleton pregnancy, no participation in another 
clinical trial, no use of fish oil supplements from the beginning of 
pregnancy and no use of folate or vitamin B 12 supplements after 
the 16th week of gestation  [30] .
 Dietary Assessment 
 Dietary intake was recorded using a food frequency question-
naire (FFQ) containing standard portion sizes, which was based 
on previous studies evaluating dietary intakes (the MONICA 
study  [32] , the nutrition protocol of Freiburg, Germany, and the 
GISELA study). To address reproducibility and the possibility of 
changes in dietary intakes, nutritional assessment was completed 
in week 20  8 1 (w20) and week 30  8 1 (w30) of gestation. Intake 
of nutrients was calculated from the portion size and frequency 
of food consumption using the German nutrient database 
(Bundeslebensmittelschlüssel)  [33] , version II.3. It was decided to 
use only one nutrient database because of possible systematic er-
rors, which would increase in case of using three different data-
bases  [34] . Nutrient intake is expressed as intake per 1,000 kcal. 
Thirty-three food items were included in the questionnaire pri-
mary focused on dietary sources of DHA and folate. For this rea-
son, certain food categories like milk, dairy products and bever-
ages were disregarded. We did not assess the intake of processed 
food fortified with folate because the used nutrient database con-
tained only incomplete information about those foods.
 In the FFQ, details on the following supplements were also 
recorded: multivitamin juice/pills, beer yeast, wheat bran, flax-
seeds and evening primrose oil. However, intakes from the 
NUHEAL study supplements were not included.
 In addition to the amount and frequency of food consump-
tion, women were asked to provide information on the mode of 
preparation and special dietary habits (e.g. vegetarian diet). Single 
food items were combined in several food groups such as meat 
(beef, pork, poultry, liver and processed meat including sausage); 
seafood (divided into lean fish, medium fat fish and fatty fish); 
vegetables (raw vegetables, cooked vegetables and legumes), fats 
(for warm dishes, cold dishes or spreads), fruits, soy products, 
cheese, eggs, baked goods and potatoes. The frequency of intake 
was categorized into never/1 or 2–3 times per day/1 or 2–3 or 4–6 
times per week/1–3 times per month. Record sheets were checked 
by an experienced dietician for the presence of implausible 
amounts or inadequate description to ensure accuracy. Body 
height of the participants was determined in w20 of gestation and 
body weight in both w20 and w30. Estimated basal metabolic rate 
was calculated from weight and height based on the formula of 
Schofield  [35] . Participants whose energy intake calculated from 
the FFQ was less than the basal metabolic rate were defined as 
‘under-reporters’ and excluded from nutritional analyses.
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 Statistical Analyses 
 Data were analyzed with SPSS for Windows 12.0 (SPSS, Chi-
cago, Ill., USA). Normal distribution was examined using the Kol-
mogorov-Smirnov analysis. One-way analysis of variance and the 
post hoc Bonferroni test were used to evaluate differences be-
tween study groups in normally distributed data. For non-nor-
mally distributed data, the Mann-Whitney U test was employed. 
A linear model was used to obtain more information regarding 
variables affecting dietary intake. Non-normally distributed data 
were logarithmized before the test. Statistical significance was 
considered at p  ! 0.05. Correlations between parameters were es-
timated by computing Pearson’s correlation coefficient in the case 
of normally distributed values and the Spearman correlation co-
efficient (  ) in the case of other distributions, respectively.
 Results 
 Three hundred and eleven pregnant women agreed to 
participate in the clinical trial. A total of 271 women with 
an average age of 30.8 years (mean) completed the study 
protocol ( table 1 ). More than 98% of the women were 
Caucasians and  1 96% were living in a partnership. Most 
of the women consumed omnivorous diets,  ! 1% of the 
participants followed a vegetarian diet (n = 2). Forty-
eight percent of the participants were living in urban ar-
eas. At the time of study entry, 42% of the participating 
women were not working, 32% had a full time job and 
13% worked part time. Women from Munich were sig-
nificantly older than those from the two other centers
(p  ! 0.001). In w20 and w30, 12 and 14%, respectively, of 
the participants reported to smoke. An overview about 
socioeconomic characteristics of the three study samples 
is shown in  table 2 .
 In w20, 15 women were excluded from analysis (Ger-
many: n = 12; Spain: n = 2, and Hungary: n = 1), because 
of apparent under-reporting of dietary intake. Thus, 256 
subjects were included in the calculations. In w30, 35 
women were excluded (Germany: n = 24; Spain: n = 5, and 
Hungary: n = 6), because of apparent under-reporting, 
thus a total of 236 FFQs were included. Women who 
dropped out of the study did not differ in age, ethnic 
group, residency, family status and education from the 
remaining participants.
 Body Weight Progress and Birth Outcomes 
 Body weight and weight gain (on average 5.7 kg from 
w20 to w30) did not significantly differ between the three 
cohorts, but in w20 the body mass index was lower in 
Munich compared to Granada (p = 0.047,  table 1 ). Body 
mass index increased from w20 to w30 by 2.1  8 1.3 kg/
m 2 (mean  8 SD). The birth outcomes, birth weight, head 
Table 1. Characteristics of the study cohorts at study entry
Germany
(n = 68)
Spain
(n = 147)
Hungary
(n = 55)
p
value
Age, years 33.583.5a, b 30.184.9a 29.484.8b <0.001
Weight, kg 67.889.9 67.288.9 69.6811.8 NS
Height, cm 16686.0 16286.0 16587.0 NS
BMI 24.483.3a 25.883.5a 25.584.6 0.003
Vegetarians, n 2 0 0 NS
Smokers, n 3 27 1 NS
Cigarettes n/week 22 55 28 NS
BMI = Body mass index; NS = no significant difference. Sta-
tistical differences were tested with ANOVA and the post hoc 
Bonferroni test (means 8 SD).
a, b Common superscripts indicate a significant difference.
Cigarettes n/week are related to the subgroup of smokers. 
Table 2. Socioeconomic characteristics of the study participants 
(frequency in %)
Spain Germany Hungary
Education
None – 1.4 –
Primary school 39.7 62.6 5.5
General qualification
for university 54.4 30.6 60.0
University 5.9 4.1 30.9
Other – – 3.6
Graduation
None 5.9 40.8 74.5
With graduation 44.1 25.2 –
Degree 8.8 4.8 –
University graduation 38.2 23.8 23.6
Other 2.9 2.7 1.8
Career
Appointee 2.9 18.4 –
Employee 52.9 29.3 96.4
Manager 19.1 1.4 –
Worker 1.5 22.4 1.8
Freelancer 7.4 8.2 1.8
Current job
None 23.5 46.3 52.7
<15 h per week 2.9 2.7 3.6
Half time 16.2 15.0 3.6
Full time 48.5 27.2 25.5
Maternity leave 8.8 – 14.5
University/education – 0.7 –
Family status
Single 1.5 6.1 –
Partnership 98.5 93.9 100.0
Habitat
Urban area 57.4 31.3 80.0
Rural area 42.6 68.0 20.0
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circumference and placental weight were not significant-
ly different between the three cohorts (data not shown). 
Birth length was significantly higher in the German sam-
ple (p  ! 0.001) compared with the two other centers.
 Nutrient Intake 
 The highest calculated energy intake was observed in 
Hungary ( table 3 ). German women had the lowest energy 
intake from the FFQs (p  ! 0.001 vs. both other cohorts), 
while there was no significant difference between Spain 
and Hungary. Dietary fat intake contributed about 45% 
to energy intake. Spanish women had a higher total fat 
intake than both other groups at both time points ( ta-
ble 3 ). The carbohydrate intake was significantly higher 
in Germany than in Spain in w20 and w30, and there was 
also a significant difference between Spain and Hungary 
in w30. Analysis of the total protein intake and protein 
intake in grams per kilogram body weight was signifi-
cantly lower in German and Spanish than in Hungarian 
cohorts.
 Our estimate of folate intake includes natural sources 
of folate in food, folic acid and folic acid equivalents. The 
daily intake of folate differed significantly between the 
three centers. The highest intake was observed in Hun-
garian women ( table 3 ). Significant differences were 
found between Hungarian and German as well as be-
tween Hungarian and Spanish women. Other variables 
like age, and the mother’s education level and family sta-
Table 3. Dietary intake in w20 and w30 of gestation (medians and interquartile ranges: P25–P75)
Germany Spain Hungary Total study population
1,000 kcal day 1,000 kcal day 1,000 kcal day 1,000 kcal day
w20
Energy, kcal 2,204a *, b * 3,078a * 3,267b * 2,968
1,765–3,520 2,492–3,549 2,462–3,994 2,271–3,520
SFA, g 16.0 35.4d, e * 15.9 48.1d 16.6 48.0e * 16 45.8
14.2–20.3 27.9–46.7 14.4–17.9 39.5–59.3 14.4–18.7 38.1–66.7 14.3–18.3 35.2–59.3
MUFA, g 19.7a * 41.4d *, e 25.4a *, b * 74.2d *, f * 19.3b * 60.9e, f * 22.90 65.6
17.5–23.4 32.8–57.8 22.6–28.4 61.0–93.2 17.2–21.3 44.7–72.1 19.3–26.7 47.8–85.2
PUFA, g 9.9b * 20.1d *, e * 10.2c * 29.5d *, f * 12.4b *, c * 39.0e *, f * 10.7 29.7
8.0–12.8 16.5–31.1 9.2–11.8 24.2–40.6 10.9–16.2 29.6–51.9 9.1–12.6 21.9–42.0
DHA, mg 111a 235d *, e * 134a, b 413d *, f 107b 315e *, f 126 355
66.3–140 154–244 103–176 297–327 86.3–151 231–444 91.5–165 240–477
n-6/n-3 ratio 9.0a * 9.0d * 9.1b * 9.1e * 12.0a, b * 12.0d *, e * 9.3 9.3
7.9–13.1 7.9–13.1 8.0–10.3 8.0–10.3 9.1–14.5 9.1–14.5 8.1–11.5 8.1–11.5
Folate, g 123a, b 271d, e * 110a, c * 324d, f * 152b, c * 429e *, f * 116 327
104–147 206–354 97–124 270–403 123–166 319–610 103–139 262–424
w30
Energy, kcal 2,203a *, b * 2,934a * 2,926b * 2,713
1,774–2,612 2,301–3,402 2,354–3,662 2,205–3,365
SFA, g 17.8a 37.0d, e 16.3a 45.4e 16.1 48.0d 16.4 44.0
13.9–21.2 30.4–48.2 14.5–17.6 35.4–57.9 14.5–17.8 37.8–59.5 14.5–17.9 35.4–56.7
MUFA, g 19.2a * 40.0d *, e 25.5a *, c * 71.9d *, f * 18.5c * 54.3f *, e 23.4 61.8
17.9–22.1 32.8–61.5 23.5–28.0 55.8–89.3 17.0–21.3 42.7–73.7 19.2–26.6 48.1–85.1
PUFA, g 9.7a 21d *, e * 10.8b * 29.5d *, f 12.4a, b * 37.4e *, f 11.0 29.4
7.7–12.8 15.8–27.2 9.5–12.3 24.0–38.7 10.4–15.8 27.9–56.1 9.5–12.9 22.6–39.2
DHA, mg 107a 259d *, e 136a, b * 403d *, f 110b* 317e, f 123 372
68.3–180 136–363 109–185 325–494 93.3–138 239–458 98.8–175 271–465
n-6/n-3 ratio 9.5a 9.5 9.3c * 9.3f * 12.0b, c * 12.0e, f * 9.7 9.7
7.0–13.0 7.0–13.0 8.1–10.8 8.1–10.8 9.4–15.2 9.4–15.2 8.2–11.9 8.2–11.9
Folate, g 113b * 254d, e * 109c * 304d *, f * 143b *, c * 396e *, f * 116 311
92.1–147 193–320 94.3–124 254–360 119–165 321–526 97.2–138 254–393
Statistical differences were tested using the Mann-Whitney U test. SAF = Saturated FAs; MUFA = monounsaturated FAs; PUFA = 
polyunsaturated FAs. a–f Common superscripts indicate a significant difference; * p < 0.001. 
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tus had no effect on the folate intake. The correlation be-
tween the two time points was statistically significant for 
the whole study population (r = 0.5; p  ! 0.001). Only 7 and 
5% of the women attained the recommended folate intake 
of 600   g/day during pregnancy in w20 and w30, respec-
tively. The folate intake of 400   g/day, which is recom-
mended for pregnant women in Hungary (Hungarian 
National Center of Epidemiology), was met by 29 and 
23% of the total study population in w20 and w30, respec-
tively.
 In all study centers, the two most common sources of 
folate were vegetables and fruits ( table 4 ). Bread was im-
portant for the supply in Spain and Germany, but not in 
Hungary, where meat products and sausages, especially 
liver, were the major folate sources. Additionally, nuts 
and oil seeds contributed to a larger extent to the folate 
supply in Spain and Hungary than in Germany. The cor-
relation between the estimated daily folate intake and the 
vegetable and fruit intake was significant in the whole 
study population (r = 0.6; p  ! 0.001). Daily folate and liv-
er intake showed the highest correlation coefficient in 
Hungary (r = 0.7; p  ! 0.001), while there was no correla-
tion in Germany.
 Fatty Acids 
 The FA composition and consumption for the three 
study centers is shown in  table 3 . Values for monounsatu-
rated FAs were significantly higher in Spain compared to 
the other centers at both time points. Saturated FA intake 
was similar in the three centers in w20, whereas in w30 
German women showed a significantly higher intake 
than Spanish women. The n-6 FA intake as well as the 
ratio of n-6 (linoleic and arachidonic acid) to n-3 (  -lino-
lenic acid, eicosapentaenoic acid and DHA) polyunsatu-
rated FAs was high in all centers. Women from Hungary 
had the highest n-6 FA intake as well as the highest n-6/
n-3 ratio, whereas women from Spain showed the lowest 
n-6/n-3 ratio and the highest n-3 FA intake. Significant 
differences in the n-6 intake were found between Hun-
gary and the two other centers at both time points.
 The highest DHA intake was found in the Spanish co-
hort (significantly different from both Hungarian and 
German cohorts). DHA intake in w20 and w30 correlated 
with each other (r = 0.519; p  ! 0.001) and with daily fish 
intake (r = 0.55; p  ! 0.001). The three most common 
sources for DHA intake from food in all three study sam-
ples were fish, poultry and eggs ( table 5 ). The linear mod-
el showed no effect for family status, age, education level 
and urban/rural residency on DHA intake.
 Supplement Intake 
 Forty-three percent of the women took dietary supple-
ments in w20 and 39% in w30. Hungary provided the big-
gest group of participants taking one or more supple-
ments in w20 and w30 (78 and 62%, respectively). In the 
remainder, the number of women taking supplements 
was about half of those in Hungary (Germany: 36 and 
28%, and Spain: 32 and 35%). Multivitamin juices and 
tablets were the most common supplements, followed by 
beer yeast, wheat bran and flaxseeds.
Table 4. Important food sources of folate, and their percentage to 
total folate intake
w20
Germany Spain Hungary
(n = 56) (n = 146) (n = 54)
Vegetables 31.2 23.4 30.0
Fruits 11.9 18.5 13.4
Bread 11.9 10.6 6.4
Meat products 3.5 5.8 10.0
Nuts, oil seeds 5.9 7.9 12.8
Potato products 7.4 7.6 6.7
w30 (n = 43) (n = 143) (n = 50)
Vegetables 25.6 23.4 28.9
Fruits 13.8 17.6 15.0
Bread 10.8 10.9 7.0
Meat products 3.8 5.2 8.1
Nuts, oil seeds 4.9 8.9 13.1
Potato products 7.0 8.3 6.6
Table 5. Important food sources of DHA, and their percentage to 
total DHA intake
Germany Spain Hungary
w20 (n = 56) (n = 146) (n = 54)
Fish 42.2 48.1 22.0
Poultry 20.3 23.7 35.5
Eggs 7.1 6.9 9.4
Bread 14.9 4.3 2.5
Sweets and pastries 2.1 2.7 2.1
w30 (n = 43) (n = 143) (n = 50) 
Fish 47.2 51.0 25.6
Poultry 18.9 25.2 37.0
Eggs 8.3 5.5 7.2
Bread 16.8 13.1 11.7
Sweets and pastries 2.4 2.7 2.5
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 FFQ w20 versus FFQ w30 
 A comparison between the two evaluation time points 
showed significant differences in energy (p = 0.01) and 
retinol (p = 0.03) intake in the total study population. 
Correlations between FFQ w20 and FFQ w30 were statis-
tically significant for all nutrients (p  ! 0.001). Spearman’s 
rank correlation coefficient ranges from r sp = 0.49 to
r sp = 0.62.
 Discussion 
 This study on the nutrient intake of pregnant women 
from three different European cohorts indicates a poor 
folate supply, as well as considerable differences in nutri-
ent supply between the three study centers. To decrease 
any potential effects of incomplete reporting, we ex-
pressed nutrient intakes per energy intake, i.e. compared 
the nutrient density between the three study centers. 
About one third of the folate intake was provided by veg-
etables. Leafy greens such as spinach, legumes, and some 
fruits as well as vegetables are rich food sources of folate. 
Staple foods such as bread or potatoes contribute only 
moderately, but consumed in large amounts they can 
provide a significant portion of the total folate intake  [36] . 
The relative contribution of other folate sources varied 
from sample to sample. Nuts and meat products played a 
particularly important role in the Hungarian cohort, 
where women showed the highest liver consumption 
(median; w20: 88 g/week; w30: 59 g/week). German par-
ticipants obtained their folate supply primarily from veg-
etables, pastries, fruits and cheese, whereas meat prod-
ucts played only a minor role and liver consumption was 
negligible. In all centers, about 7% of total dietary folate 
was supplied by potatoes and potato products, which 
confirms that staple food can significantly contribute to 
the total folate intake  [36] . While our results indicate that 
vegetables and fruits were the primary sources of dietary 
folate intake, Siega-Riz et al.  [37] reported that folate-for-
tified grains and ready-to-eat cereals followed by differ-
ent kinds of juices were the most important sources for 
folate intake in pregnant women in the US, where cereals 
and grains are generally fortified with folic acid.
 The average dietary folate intake of the study popula-
tion was 327   g/day in w20 and 311   g/day in w30. Thus, 
only 6% of the participants reached the intake of 600   g/
day recommended in Germany, Austria and Switzerland, 
and only 26% of the participants reached 400   g/day. 
However, we may have underestimated total folate intake, 
because we could not account for some fortified foods. 
The consumption of a folate-rich diet and folic acid sup-
plements is recommended for women of childbearing age 
 [38–40] . Folic acid fortification of foods is an alternative 
option to cover the needs of women who get pregnant 
 [41–43] . Nationwide fortification programs of staple 
foods such as flour are well established in many countries 
around the world  [7, 41, 44, 45] , primarily because folic 
acid supplementation during the first weeks of pregnancy 
decreases the incidence of neural tube defects. For ex-
ample, cereal fortification with folic acid in Canada has 
reduced the prevalence of neural tube defects  1 50%  [46] . 
The rather low folate intake in pregnant women found in 
this study was also reported in other studies  [5, 37] . The 
folate intake of the Hungarian subjects reported in the 
present study exceeded the results of a previous Hungar-
ian nutritional survey carried out between 1990 and 1994 
 [47] . This trial revealed a mean daily folate intake of 166 
  g in w20 and 149   g in w30 of gestation, and hence fo-
late intake may have increased in pregnant Hungarian 
women during the last decade. However, the 3rd   Hungar-
ian dietary survey showed that folic acid intake of adult 
women did not meet the criteria of the Hungarian recom-
mendations  [48] . German non-pregnant women aged 
25–51 years were reported to have a mean daily folate in-
take of about 225   g/day  [49] and, thus, to have a lower 
intake than the NUHEAL participants, potentially due to 
an increased health consciousness of a population par-
ticipating in a dietary intervention trial during pregnan-
cy and different data collection methods.
 Also Ortega et al.  [50] showed in their survey that in 
319 Spanish women aged 18–35 years none of them 
reached the recommended 400   g/day of folate.
 DHA is primarily contained in fatty sea fish such as 
salmon, mackerel and herring, as well as in certain micro 
algae  [51] . In the used FFQ, women were asked to separate 
their intake into lean fish, medium fat fish and fatty fish 
as well as into the kind of preparation (cooked, fried, con-
served, crumbed or soup). Eighty-five percent of the 
Spanish women ate fatty fish at least once a month. In 
comparison, only 4% of the Hungarian women consumed 
fatty fish with high DHA contents, they rather consumed 
red and sea bass, swordfish and trout, with moderate fat 
and lower DHA contents. German participants tended to 
eat more lean fish (e.g. halibut, cod or sole pike) with low 
DHA contents, which possibly explains their lower DHA 
intake.
 Our results agree with previous data reporting a high-
er availability of fish in Spain (75 g/day) than Hungary
(4 g/day) and Germany (12 g/day)  [52] . Authors reported 
also that cooking and frying are the main types of pre-
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paring fish, followed by the use of canned fish, while fish 
soups play only a minor role. Other possible dietary DHA 
sources are meats and eggs. A European Commission-
funded evidence-based consensus recommendation re-
cently advised that pregnant and lactating women should 
reach an average intake of at least 200 mg DHA per day 
 [29] . Nearly 90% of the participating women achieved 
this intake. The WHO has recommended an n-6/n-3 FA 
ratio between 3: 1 and 4: 1  [53] . The subjects in this study 
reached an n-6/n-3 ratio of 10: 1, i.e. much higher than the 
WHO goal. The ratio in Spanish women (9.4: 1) is very 
similar to the 9.8  8 7.3 previously reported in 162 Span-
ish women  [54] . A somewhat higher dietary DHA intake 
would contribute to lowering the n-6/n-3 ratio.
 While mean macronutrient intake of our study popu-
lation seems quite adequate, our findings clearly show 
shortcomings particularly in folate intake, and to a lesser 
extent also in the amount of DHA intake, in pregnant 
women in the study population. While there were differ-
ences between the three cohorts studied, intake in w20 
and w30 within study populations was very similar. Oth-
er variables like age, family status or education level did 
not have significant effects either on folate or on DHA 
intake from food. An increased dietary micronutrient 
density and micronutrient supplementation could en-
hance micronutrient intake  [37] .
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